The R&D budget for Health and Medical Sciences in Norway is forecasted to remain around 0.18% of GDP from 2024 to 2026, and then slightly increase to 0.19% in 2027 and 2028. This indicates a stable investment level with a minor upward trend starting in 2027. Comparatively, the value was also 0.18% in 2023, showing no significant year-on-year variation, but a modest increase is projected towards the end of the forecast period. With a consistent CAGR, the average annual variation remains minimal and indicates steady, but slow, growth.
Future trends to watch for include shifts in government policies towards more significant healthcare investments, potential impacts from technological advancements in medical research, and economic conditions that could affect budget allocations. Additionally, consider the global health landscape, which could prompt increased funding to address new health challenges. Monitoring these factors will be crucial in evaluating the future trajectory of R&D budgets in Norway's health and medical sector.
